Barclays Maintains Overweight on Copa Holdings, Lowers Price Target to $85
Barclays analyst Pablo Monsivais maintains Copa Holdings (NYSE:CPA) with a Overweight and lowers the price target from $96 to $85.
Barclays Maintains Overweight on Phillips 66, Raises Price Target to $113
Barclays analyst Theresa Chen maintains Phillips 66 (NYSE:PSX) with a Overweight and raises the price target from $95 to $113.
Credit Suisse Maintains Neutral on CME Group, Lowers Price Target to $233
Credit Suisse analyst Gautam Sawant maintains CME Group (NASDAQ:CME) with a Neutral and lowers the price target from $242 to $233.
springbig Enters Into An Exclusive Partnership With Subscription-Based Service Kind+
springbig (NASDAQ: SBIG) (NASDAQ: SBIGW), a leading provider of SaaS-based marketing solutions, consumer mobile app experiences, and omnichannel loyalty programs to the cannabis industry, entered into an exclusive partners
Nephros Sees Prelim. Q2 Sales $2.9M, Up 27% YoY; Number of Active Customer Sites Up 21% YoY
Second Quarter Revenue of $2.9 Million, Year-Over-Year Increase of 27%;
Number of Active Customer Sites Climbs 21% Year-Over-Year
SOUTH ORANGE, NJ, July 06, 2022 (GLOBE NEWSWIRE) --
Citigroup Maintains Buy on Liberty Energy, Raises Price Target to $24
Citigroup analyst Scott Gruber maintains Liberty Energy (NYSE:LBRT) with a Buy and raises the price target from $22 to $24.
H.B. Fuller And 2 Other Stocks Insiders Are Buying
Although the Nasdaq Composite jumped 1.75% on Tuesday, there were a few notable insider trades.
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $49
Citigroup analyst Scott Gruber maintains Helmerich & Payne (NYSE:HP) with a Neutral and raises the price target from $44 to $49.
Vera Therapeutics Completes Patient Enrollment In Phase 2b ORIGIN Clinical Trial Of Atacicept For The Treatment of IgA Nephropathy
Vera Therapeutics, Inc. (NASDAQ:VERA), a late-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological disease, today announced completion of
Why Resolute Forest Products Shares Are Rallying Today?
Through its wholly-owned subsidiary Domtar Corporation, the Paper Excellence Group has agreed to acquire Resolute Forest Products Inc (NYSE:RFP). Fairfax Financial Holdings Limited,…